Revising LH cut-off for the diagnosis of central precocious puberty via triptorelin stimulation assay.
Cavarzere. Paolo P; Sandri. Marco M; Arrigoni. Marta M; Guardo. Chiara C; Gaudino. Rossella R; Antoniazzi. Franco F
Key Findings
- A post‑triptorelin LH cut‑off of 5 IU/L predicts early central precocious puberty better than the previous 15 IU/L threshold.
- Girls who later showed puberty activation already had higher baseline LH, higher LH/FSH ratios, and faster growth at the first test.
- Adding LH/FSH ratio or growth speed to the LH value did not improve diagnostic accuracy.
Practical Outcomes
- For pediatric doctors, using a 5 IU/L LH cut‑off after triptorelin can catch early puberty sooner. This finding has little direct relevance for biohackers or self‑directed health‑optimization protocols aimed at adults.
Summary
Scientists studied a hormone test (triptorelin) used to spot early puberty in girls and found that a much lower LH level (5 IU/L) after the test can signal the condition, instead of the older 15 IU/L rule.
Abstract
Precocious puberty (PP) in girls is defined by thelarche before age 8. The diagnostic gold standard is an increased LH level following gonadotropin-releasing hormone (GnRH) stimulation. Alternatively, GnRH analogues like triptorelin can be used, though their interpretation varies. Since 2000, we have used a triptorelin-induced LH cut-off of 15 IU/L, 4 h post-stimulus. However, many girls showed LH values below this threshold despite evident pubertal progression. To establish a new LH threshold post-triptorelin stimulation for earlier diagnosis of central precocious puberty (CPP) in girls showing pubertal progression and to evaluate additional parameters for diagnostic accuracy. We enrolled 186 girls with thelarche onset between ages 1-8 and a GnRH analogue assay performed between 2015-2019 without signs of axis activation. Within this cohort, 62 patients repeated the triptorelin test due to rapid pubertal progression. The assay involved administering 100 mcg/m² of triptorelin and measuring LH, FSH, and estradiol levels before and four hours post-injection. Patients with axis activation at the second test had significantly higher post-stimulus LH levels at the first test compared to those below 15 IU/L. They also had higher basal LH levels, elevated LH/FSH ratio, and increased growth velocity. Statistical analysis identified a new post-stimulus LH threshold of 5 IU/L. We propose a LH value of 5 IU/L after triptorelin administration as a new threshold for early CPP diagnosis. While the LH/FSH ratio and growth velocity are associated with axis activation, they did not significantly enhance diagnostic accuracy when combined with the LH value.
Study Information
pubmed
2024
2024-10-09T00:00:00.000Z
10.1007/s12020-024-04055-0
3
25